Public recall detail

Alere Inc. initiating voluntary withdrawal of Alere INRatio® and INRatio® 2 PT/INR Monitoring Systems that may pose serious health risks

medium
Recall Safety notice
Quick summary

Quick summary: Alere Inc. initiating voluntary withdrawal of Alere INRatio® and INRatio® 2 PT/INR Monitoring Systems that may pose serious health risks .

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Alere Inc. initiating voluntary withdrawal of Alere INRatio® and INRatio® 2 PT/INR Monitoring Systems that may pose serious health risks .

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

Brand

Issue

As Health Canada previously communicated, Alere Inc. is withdrawing the Alere INRatio® and INRatio® 2 Prothrombin Time (PT) Monitoring Systems (professional use and patient self-test) devices from the Canadian market. These devices measure blood clotting time in patients requiring warfarin and other oral blood-thinning medicines. There is a risk that the Alere devices provide an inaccurate low reading. This could result in an improper dosage of warfarin or other blood-thinning medications being administered, leading to excessive bleeding, which may result in serious health concerns that could potentially be fatal.

What you should do

  • Consult with your doctor if you have used this product and have health concerns.
  • Report any adverse; incidents to Health Canada. Patients should speak with their healthcare providers prior to making any changes to their current PT/INR monitoring practices.
  • Alere Inc. has advised that patients and healthcare providers should transition to another monitoring system; however, they may continue to use the Alere INRatio® or INRatio® 2 PT/INR Monitoring System in the short term as long as they adhere to the precautions and recommendations found in the Medical Device Correction notification of December 2014 Customer letter – December 2014) and current product insert labelling.
  • Patients and healthcare providers who wish to receive an additional copy of the labelling for this product can contact Alere at 1-877-866-5313. Alere Inc. has also committed to providing instructions by email or fax to patients and healthcare providers about the return or disposal of the affected products. Alere Inc. will provide this information as soon as it is available.
  • IN Ratio/IN Ratio 2 Prothrombin Time /INR Test Strips will continue to be manufactured and distributed until such time as necessary to allow patients to safely transition to another monitoring method. Users and healthcare providers can check the Alere Inc. website for updates.
Additional official information
Background{"text":"In 2014, Alere initiated a voluntary recall action to inform users of the INRatio® Patient Self-Testing Monitoring System, INRatio® PT Monitoring System (Professional Use) and INRatio® Prothrombin Time/INR Strips that they may provide an INR result that, in certain cases, is significantly lower than a result obtained using a laboratory INR system. That recall can be found here: INRatio Patient Self-Testing Monitoring System, INRatio PT Monitoring System (Professional Use) and INRatio Prothrombin Time/INR Strips (2014-12-09)."}
Companies
Audiences

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...